Histogram Analysis of Whole-Lesion Enhancement in Differentiating Clear Cell from Papillary Subtype of Renal Cell Cancer
Authors:
- Hersh ChandaranaHCHersh Chandarana
- Andrew B. RosenkrantzARAndrew B. Rosenkrantz
- Thais C. MussiTMThais C. Mussi
- Sooah KimSKSooah Kim
- Afshan A. AhmadAAAfshan A. Ahmad
- Sean D. RajSRSean D. Raj
- John McMenamyJMJohn McMenamy
- Jonathan MelamedJMJonathan Melamed
- James S. BabbJBJames S. Babb
- Berthold KieferBKBerthold Kiefer
- Atilla P. KiralyAKAtilla P. Kiraly
Open Access
- 1 December 2012
- journal article
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 265 (3) , 790-798
Abstract
Histogram analysis of whole-lesion enhancement as well as histogram distribution parameters kurtosis and skewness can be used to discriminate clear cell renal cell cancer (RCC) from papillary RCC with high accuracy and high interreader agreement. PurposeTo compare histogram analysis of voxel-based whole-lesion (WL) enhancement to qualitative assessment and region-of-interest (ROI)-based enhancement analysis in discriminating the renal cell cancer (RCC) subtype clear cell RCC (ccRCC) from papillary RCC (pRCC).Materials and MethodsIn this institutional review board–approved, HIPAA-compliant retrospective study, 73 patients underwent magnetic resonance (MR) imaging prior to surgery for RCC between January 2007 and January 2010. Three-dimensional fat-suppressed T1-weighted gradient-echo corticomedullary phase acquisitions, obtained before and after contrast agent administration, were transferred to a workstation at which automated registration followed by semiautomated segmentation of the RCC was performed. Percent enhancement was computed on a per-voxel basis: (SIpost – SIpre)/SIpre ·100, where SIpre and SIpost indicate signal intensity before and after contrast enhancement, respectively. The WL quantitative parameters of mean, median, and third quar...Keywords
This publication has 28 references indexed in Scilit:
- Age-Adjusted Incidence, Mortality, and Survival Rates of Stage-Specific Renal Cell Carcinoma in North America: A Trend AnalysisEuropean Urology, 2011
- Histological Subtype is an Independent Predictor of Outcome for Patients With Renal Cell CarcinomaJournal of Urology, 2010
- Prognostic Impact of Histological Subtype on Surgically Treated Localized Renal Cell CarcinomaJournal of Urology, 2009
- The Pathology of Renal Epithelial NeoplasmsSeminars in Oncology, 2006
- Current trends in molecular classification of adult renal tumorsUrology, 2006
- RENAL CELL CARCINOMA 2005: NEW FRONTIERS IN STAGING, PROGNOSTICATION AND TARGETED MOLECULAR THERAPYJournal of Urology, 2005
- Comparisons of Outcome and Prognostic Features Among Histologic Subtypes of Renal Cell CarcinomaAmerican Journal of Surgical Pathology, 2003
- INCREASING INCIDENCE OF ALL STAGES OF KIDNEY CANCER IN THE LAST 2 DECADES IN THE UNITED STATES: AN ANALYSIS OF SURVEILLANCE, EPIDEMIOLOGY AND END RESULTS PROGRAM DATAJournal of Urology, 2002
- Rising Incidence of Renal Cell Cancer in the United StatesJAMA, 1999
- The small (less than or equal to 3.0 cm) renal parenchymal tumor: detection, diagnosis, and controversies.Radiology, 1991